Narayana Hrudayalaya Ltd. (IN:NH)
:NH
NH Stock Chart & Stats
₹1756.45
₹14.10(1.04%)
At close: 4:00 PM EST
₹1756.45
₹14.10(1.04%)
Day’s Range― - ―
52-Week Range₹1,380.05 - ₹2,371.60
Previous CloseN/A
Volume860.19K
Average Volume (3M)80.08K
Market Cap
₹331.90B
Enterprise Value₹361.67B
Total Cash (Recent Filing)₹18.24B
Total Debt (Recent Filing)₹23.40B
Price to Earnings (P/E)75.8
Beta0.80
Next Earnings
May 15, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)6.30
Shares Outstanding204,360,800
10 Day Avg. Volume19,057
30 Day Avg. Volume80,081
Financial Highlights & Ratios
PEG Ratio92.72
Price to Book (P/B)9.40
Price to Sales (P/S)6.22
P/FCF Ratio-354.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹2,130.00Price Target Upside21.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)53.48
Revenue Forecast (FY)₹101.35B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthThe company’s revenue more than doubled from 25.8bn in 2021 to 54.8bn in 2025, indicating sustained demand and market expansion. Durable top-line growth supports higher utilization of fixed hospital assets, long-term operating leverage, and predictable cash generation for reinvestment.
Specialized Tertiary-care FocusA clear strategic focus on tertiary and super‑specialty services (notably cardiac sciences) creates high clinical barriers to entry, strong referral networks, and pricing power. These structural advantages underpin steady, higher‑margin volumes and defensible market positioning over years.
Robust Operating Cash Flow ConversionConsistent positive operating cash flow and efficient conversion of net income into cash bolster financial flexibility. Durable cash generation funds capex and expansion without excessive reliance on markets, supporting network growth and reducing refinancing risk over the medium term.
Bears Say
Rising Total DebtAn increasing debt load over multiple years erodes financial flexibility and raises interest and refinancing exposure. If leverage continues upward it can constrain capital allocation, increase funding costs in a higher‑rate environment, and magnify downside risk during margin pressure.
Dip To Negative Free Cash Flow In 2025A swing to negative free cash flow driven by elevated capex reduces internally available funds for growth or deleveraging. Persistently lower FCF would force greater external financing, raising cost of capital and potentially slowing network expansion or clinical investments.
EBITDA Margin DeclineA declining EBITDA margin hints at rising input costs or margin dilution from growth investments. If margin erosion persists it will weaken cash flow per case, pressure profitability, and require sustained efficiency gains or price increases to restore durable earnings power.
Narayana Hrudayalaya Ltd. News
NH FAQ
What was Narayana Hrudayalaya Ltd.’s price range in the past 12 months?
Narayana Hrudayalaya Ltd. lowest stock price was ₹1380.05 and its highest was ₹2371.60 in the past 12 months.
What is Narayana Hrudayalaya Ltd.’s market cap?
Narayana Hrudayalaya Ltd.’s market cap is ₹331.90B.
When is Narayana Hrudayalaya Ltd.’s upcoming earnings report date?
Narayana Hrudayalaya Ltd.’s upcoming earnings report date is May 15, 2026 which is in 38 days.
How were Narayana Hrudayalaya Ltd.’s earnings last quarter?
Narayana Hrudayalaya Ltd. released its earnings results on Feb 13, 2026. The company reported ₹6.3 earnings per share for the quarter, missing the consensus estimate of ₹11.8 by -₹5.5.
Is Narayana Hrudayalaya Ltd. overvalued?
According to Wall Street analysts Narayana Hrudayalaya Ltd.’s price is currently Undervalued.
Does Narayana Hrudayalaya Ltd. pay dividends?
Narayana Hrudayalaya Ltd. pays a Annually dividend of ₹4.5 which represents an annual dividend yield of 0.24%. See more information on Narayana Hrudayalaya Ltd. dividends here
What is Narayana Hrudayalaya Ltd.’s EPS estimate?
Narayana Hrudayalaya Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Narayana Hrudayalaya Ltd. have?
Narayana Hrudayalaya Ltd. has 204,360,800 shares outstanding.
What happened to Narayana Hrudayalaya Ltd.’s price movement after its last earnings report?
Narayana Hrudayalaya Ltd. reported an EPS of ₹6.3 in its last earnings report, missing expectations of ₹11.8. Following the earnings report the stock price went down -2.307%.
Which hedge fund is a major shareholder of Narayana Hrudayalaya Ltd.?
Currently, no hedge funds are holding shares in IN:NH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited provides medical and healthcare services. The company operates and maintains hospitals, clinics, health centers, nursing homes, and other related activities. It offers services in various specialties, including cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology. As of June 30, 2022, the company operated through a network of 19 owned/operated hospitals, 2 managed hospitals, 4 heart centers, and 18 clinics and information centers in India, as well as a hospital in the Cayman Islands. It also provides healthcare consultancy services, including licensing of ERP solutions. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
NH Stock 12 Month Forecast
Average Price Target
₹2,130.00
▲(21.27% Upside)
Technical Analysis
Aurobindo Pharma Ltd
―
Fortis Healthcare Ltd.
―
HealthCare Global Enterprises Ltd.
―
Krishna Institute of Medical Sciences Limited
―
Global Health Limited
―